Extended survival of MHC-identical allogeneic islet grafts in diabetic BB rats--the effect of an interleukin 2 receptor-targeted immunotherapy.
Hahn
H J
HJ
Institute of Diabetes, Research, and Treatment, Karlsburg, Germany.
Kuttler
B
B
Klöting
I
I
Dunger
A
A
Besch
W
W
Diamantstein
T
T
D000818:Animals; D003922:Diabetes Mellitus, Type 1 / Q000276:immunology*; D005260:Female; D006085:Graft Survival; D007167:Immunotherapy; D016381:Islets of Langerhans Transplantation / Q000276:immunology*; D008285:Major Histocompatibility Complex / Q000276:immunology*; D008297:Male; D051381:Rats; D011913:Rats, Inbred BB; D011917:Rats, Inbred Lew; D015375:Receptors, Interleukin-2 / Q000502:physiology*
D015375:Receptors, Interleukin-2